VNDA logo

Vanda Pharmaceuticals Inc. (VNDA)

Profile

Full Name

Vanda Pharmaceuticals Inc.

Ticker

NASDAQ: VNDA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 12, 2006

Indexes

Not included

Website

https://www.vandapharma.com

Employees

368

Key Details

Price

$4.52(+2.96%)

Market cap

$267.08M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$198.77M(+3.18% YoY)

Annual EPS

-$0.33(-925.00% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.52
    VNDA price is $4.52

    30-Day Relative Volume

    0.66
    VNDA 30-day relative volume is 0.66

    Price Performance

    Price Today change

    +2.96%
    VNDA price is up +2.96% today

    Price YTD change

    -5.64%
    VNDA price is down -5.64% since January 1st

    Price 1-year change

    -8.69%
    VNDA price is down -8.69% year-on-year

    Price 3-year change

    -54.62%
    VNDA price is down -54.62% over the past 3 years

    Price Range

    Price All-time high

    $33.44
    VNDA price is currently -86.48% below its historical high of $33.44

    Price 3-year low

    $3.30
    VNDA price is currently +36.97% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $267.08M
    VNDA market capitalization is $267.08 million

    Market cap 3-year change

    -52.59%
    VNDA market capitalization is down -52.59% over the past 3 years

    Market cap All-time high

    $1.65B
    VNDA market capitalization is currently -83.82% below its historical high of $1.65 billion

    Market cap sector rank

    54.28%
    VNDA market capitalization is higher than 54.28% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.37%
    VNDA shares outstanding is up +1.37% year-on-year

    Shares Outstanding 3-Year Change

    +4.47%
    VNDA shares outstanding is up +4.47% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.54
    VNDA beta is 0.54

    200-day SMA

    $4.57
    VNDA price is currently -1.01% below its 200-day simple moving average

    50-day SMA

    $4.57
    VNDA price is currently -0.99% below its 50-day simple moving average

    RSI

    49.37
    VNDA 14-day relative strength index is 49.37

    Volume

    0.66
    VNDA 30-day relative volume is 0.66

    ATR

    $0.16
    VNDA average true range is $0.16

    10-day Historical Volatility

    32.03%
    VNDA 10-day historical volatility is 32.03%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $198.77M
    VNDA annual revenue is $198.77 million

    Revenue Analysts estimate

    $224.84M
    VNDA annual revenue is currently -11.60% lower than the consensus analysts' forecast

    Revenue 1-year change

    +3.18%
    VNDA annual revenue is up +3.18% year-on-year

    Revenue Sector rank

    73.96%
    VNDA annual revenue is higher than 73.96% of companies in Healthcare sector

    EPS

    EPS

    -$0.33
    VNDA annual earnings per share is -$0.33

    EPS Analysts estimate

    -$1.81
    VNDA annual earnings per share is currently -81.73% lower than the consensus analysts' forecast

    EPS 1-year change

    -925%
    VNDA annual earnings per share is down -925% year-on-year

    EPS Sector rank

    67.09%
    VNDA annual earnings per share is higher than 67.09% of companies in Healthcare sector

    Profit

    Gross profit

    $180.19M
    VNDA annual gross profit is $180.19 million

    Gross margin

    90.65%
    VNDA annual gross profit margin is 90.65%

    Operating profit

    -$40.66M
    VNDA annual operating income is -$40.66 million

    Operating margin

    -20.46%
    VNDA annual operating profit margin is -20.46%

    Net income

    -$18.90M
    VNDA annual net profit is -$18.90 million

    Net margin

    -9.51%
    VNDA annual net profit margin is -9.51%

    Expenses

    Total expenses

    $217.67M
    VNDA annual total expenses is $217.67 million

    Operating expenses

    $220.84M
    VNDA annual total operating expenses is $220.84 million

    Cost of goods sold

    $18.59M
    VNDA annual cost of goods sold is $18.59 million

    Selling, general & administrative expenses

    $0.00
    VNDA annual SGA is $0.00

    Depreciation and amortization

    $8.13M
    VNDA annual depreciation & amortization is $8.13 million

    Interest expense

    $0.00
    VNDA annual interest expense is $0.00

    Income tax

    -$4.02M
    VNDA annual income tax is -$4.02 million

    EBIT & EBITDA

    EBIT

    -$40.66M
    VNDA annual earnings before interest & taxes is -$40.66 million

    EBITDA

    -$32.53M
    VNDA annual EBITDA is -$32.53 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $656.20M
    VNDA annual total assets is $656.20 million

    Non current assets

    $217.31M
    VNDA annual long term assets is $217.31 million

    Current assets

    $438.89M
    VNDA annual total current assets is $438.89 million

    Cash and cash equivalents

    $102.32M
    VNDA annual cash & cash equivalents is $102.32 million

    Accounts receivable

    $47.10M
    VNDA annual accounts receivable is $47.10 million

    Inventory

    $1.73M
    VNDA annual inventory is $1.73 million

    Liabilities

    Total liabilities

    $117.66M
    VNDA annual total liabilities is $117.66 million

    Long term liabilities

    $17.68M
    VNDA annual total long term liabilities is $17.68 million

    Current liabilities

    $99.98M
    VNDA annual total current liabilities is $99.98 million

    Accounts payable

    $5.16M
    VNDA annual accounts payable is $5.16 million

    Debt

    Total debt

    $12.36M
    VNDA annual total debt is $12.36 million

    Total debt 1-year change

    +31.43%
    VNDA annual total debt is up +31.43% year-on-year

    Long term debt

    $8.09M
    VNDA annual long term debt is $8.09 million

    Short term debt

    $4.27M
    VNDA annual short term debt is $4.27 million

    Equity & Capital

    Shareholders equity

    $538.55M
    VNDA annual stockholders equity is $538.55 million

    Book value

    $538.55M
    VNDA annual book value is $538.55 million

    Retained earnings

    -$174.29M
    VNDA annual retained earnings is -$174.29 million

    Working capital

    $338.91M
    VNDA annual working capital is $338.91 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$15.76M
    VNDA annual cash flow from operations is -$15.76 million

    Cash from operations 1-year change

    -223.09%
    VNDA annual cash flow from operations is down -223.09% year-on-year

    Cash from investing

    -$17.43M
    VNDA annual cash flow from investing activities is -$17.43 million

    Cash from investing 1-year change

    -44.58%
    VNDA annual cash flow from investing activities is down -44.58% year-on-year

    Cash from financing

    -$155.00K
    VNDA annual cash flow from financing activities is -$155.00 thousand

    Cash from financing 1-year change

    -100%
    VNDA annual cash flow from financing activities is down -100% year-on-year

    CAPEX

    CAPEX

    $490.00K
    VNDA annual capital expenditures is $490.00 thousand

    CAPEX 1-year change

    +27.94%
    VNDA annual capital expenditures is up +27.94% year-on-year

    Free Cash Flow

    Free cash flow

    -$16.25M
    VNDA annual free cash flow is -$16.25 million

    Free cash flow 1-year change

    -230.83%
    VNDA annual free cash flow is down -230.83% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    90.65%
    VNDA annual gross profit margin is 90.65%

    Operating margin

    -20.46%
    VNDA annual operating profit margin is -20.46%

    Net margin

    -9.51%
    VNDA annual net profit margin is -9.51%

    ROA & ROE

    ROA

    -2.90%
    VNDA annual return on assets is -2.90%

    ROE

    -3.49%
    VNDA annual return on equity is -3.49%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    VNDA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    VNDA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.55
    VNDA price to book ratio is 0.55

    PB ratio Sector rank

    25.32%
    VNDA price to book ratio is higher than 25.32% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.31
    VNDA price to sales ratio is 1.31

    PS ratio Sector rank

    25.62%
    VNDA price to sales ratio is higher than 25.62% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$46.83M
    VNDA enterprise value is -$46.83 million

    Enterprise value Sector rank

    2.28%
    VNDA enterprise value is higher than 2.28% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.50
    VNDA EV/EBITDA is 0.50

    EV/EBITDA Sector rank

    71.3%
    VNDA EV/EBITDA is higher than 71.3% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.39
    VNDA annual current ratio is 4.39

    Quick ratio

    4.37
    VNDA annual quick ratio is 4.37

    Leverage

    Debt to equity

    0.02
    VNDA annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    VNDA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    VNDA piotroski f-score is 3

    Altman Z-Score

    1.71
    VNDA altman z-score is 1.71

    Analyst ratings

    Recent major analysts updates

    Aug 21, 25 HC Wainwright & Co.
    Buy
    May 7, 25 HC Wainwright & Co.
    Buy
    Apr 1, 25 HC Wainwright & Co.
    Buy
    Feb 18, 25 HC Wainwright & Co.
    Buy
    Feb 4, 25 HC Wainwright & Co.
    Buy
    Jan 28, 25 HC Wainwright & Co.
    Buy
    Jan 21, 25 HC Wainwright & Co.
    Buy
    Dec 23, 24 HC Wainwright & Co.
    Buy
    Oct 31, 24 HC Wainwright & Co.
    Buy
    Aug 1, 24 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with VNDA included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Vanda Pharmaceuticals Inc.?
    • Does Vanda Pharmaceuticals Inc. pay dividends?
    • What sector is Vanda Pharmaceuticals Inc. in?
    • What industry is Vanda Pharmaceuticals Inc. in?
    • What country is Vanda Pharmaceuticals Inc. based in?
    • When did Vanda Pharmaceuticals Inc. go public?
    • Is Vanda Pharmaceuticals Inc. in the S&P 500?
    • Is Vanda Pharmaceuticals Inc. in the NASDAQ 100?
    • Is Vanda Pharmaceuticals Inc. in the Dow Jones?
    • When was Vanda Pharmaceuticals Inc.'s last earnings report?
    • When does Vanda Pharmaceuticals Inc. report earnings?

    What is the ticker symbol for Vanda Pharmaceuticals Inc.?

    The ticker symbol for Vanda Pharmaceuticals Inc. is NASDAQ:VNDA

    Does Vanda Pharmaceuticals Inc. pay dividends?

    No, Vanda Pharmaceuticals Inc. does not pay dividends

    What sector is Vanda Pharmaceuticals Inc. in?

    Vanda Pharmaceuticals Inc. is in the Healthcare sector

    What industry is Vanda Pharmaceuticals Inc. in?

    Vanda Pharmaceuticals Inc. is in the Biotechnology industry

    What country is Vanda Pharmaceuticals Inc. based in?

    Vanda Pharmaceuticals Inc. is headquartered in United States

    When did Vanda Pharmaceuticals Inc. go public?

    Vanda Pharmaceuticals Inc.'s initial public offering (IPO) was on April 12, 2006

    Is Vanda Pharmaceuticals Inc. in the S&P 500?

    No, Vanda Pharmaceuticals Inc. is not included in the S&P 500 index

    Is Vanda Pharmaceuticals Inc. in the NASDAQ 100?

    No, Vanda Pharmaceuticals Inc. is not included in the NASDAQ 100 index

    Is Vanda Pharmaceuticals Inc. in the Dow Jones?

    No, Vanda Pharmaceuticals Inc. is not included in the Dow Jones index

    When was Vanda Pharmaceuticals Inc.'s last earnings report?

    Vanda Pharmaceuticals Inc.'s most recent earnings report was on July 31, 2025

    When does Vanda Pharmaceuticals Inc. report earnings?

    The next expected earnings date for Vanda Pharmaceuticals Inc. is November 5, 2025
    On this page